Table of Contents
ISRN Oncology
Volume 2011, Article ID 763245, 11 pages
http://dx.doi.org/10.5402/2011/763245
Research Article

Ten-Year Survival after Liver Resection for Colorectal Metastases: Systematic Review and Meta-Analysis

1Westmead Hospital, Wentworthville, NSW 2145, Australia
2University of Western Sydney, Penrith, NSW 2751, Australia

Received 23 February 2011; Accepted 30 March 2011

Academic Editors: M. Mandala, G. Pecher, and K. Sonoda

Copyright © 2011 Saleh Abbas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Fong, J. Fortner, R. L. Sun, M. F. Brennan, and L. H. Blumgart, “Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases,” Annals of Surgery, vol. 230, no. 3, pp. 309–321, 1999. View at Publisher · View at Google Scholar
  2. M. A. Choti, J. V. Sitzmann, M. F. Tiburi et al., “Trends in long-term survival following liver resection for hepatic colorectal metastases,” Annals of Surgery, vol. 235, no. 6, pp. 759–766, 2002. View at Publisher · View at Google Scholar
  3. J. S. Wagner, M. A. Adson, and J. A. Van Heerden, “The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment,” Annals of Surgery, vol. 199, no. 5, pp. 502–508, 1984. View at Google Scholar
  4. H. Petrowsky, M. Gonen, W. Jarnagin et al., “Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a Bi-institutional analysis,” Annals of Surgery, vol. 235, no. 6, pp. 863–871, 2002. View at Publisher · View at Google Scholar
  5. H. J. Mackay, K. Billingsley, S. Gallinger et al., “A multicenter phase II study of “adjuvant” irinotecan following resection of colorectal hepatic metastases,” American Journal of Clinical Oncology, vol. 28, no. 6, pp. 547–554, 2005. View at Publisher · View at Google Scholar
  6. N. Kemeny, Y. Huang, A. M. Cohen et al., “Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer,” The New England Journal of Medicine, vol. 341, no. 27, pp. 2039–2048, 1999. View at Publisher · View at Google Scholar · View at PubMed
  7. K. Tanaka, R. Adam, H. Shimada, D. Azoulay, F. Lévi, and H. Bismuth, “Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver,” British Journal of Surgery, vol. 90, no. 8, pp. 963–969, 2003. View at Publisher · View at Google Scholar · View at PubMed
  8. M. Minagawa, J. Yamamoto, T. Kosuge, Y. Matsuyama, S. I. Miyagawa, and M. Makuuchi, “Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation,” Archives of Surgery, vol. 142, no. 3, pp. 269–276, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. S. Zakaria, J. H. Donohue, F. G. Que et al., “Hepatic resection for colorectal metastases: Value for risk scoring systems?” Annals of Surgery, vol. 246, no. 2, pp. 183–191, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. B. Nordlinger, M. Guiguet, J. C. Vaillant et al., “Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients,” Cancer, vol. 77, no. 7, pp. 1254–1262, 1996. View at Google Scholar
  11. C. D. Mann, M. S. Metcalfe, L. N. Leopardi, and G. J. Maddern, “The clinical risk score: Emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases,” Archives of Surgery, vol. 139, no. 11, pp. 1168–1172, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. T. J. Gayowski, S. Iwatsuki, J. R. Madariaga et al., “Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors,” Surgery, vol. 116, no. 4, pp. 703–711, 1994. View at Google Scholar
  13. D. Jaeck, H. Nakano, P. Bachellier et al., “Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study,” Annals of Surgical Oncology, vol. 9, no. 5, pp. 430–438, 2002. View at Publisher · View at Google Scholar
  14. T. Kato, K. Yasui, T. Hirai et al., “Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions,” Diseases of the Colon and Rectum, vol. 46, no. 10, pp. S22–S31, 2003. View at Google Scholar
  15. G. A. Wells, B. Shea, D. O'Connell, J. Peterson, and V. Welch, “The Newcastle-Ottawa Scale (NOS) for assessing the Quality of Nonrandomised Studies in Metaanalyses,” Ottawa Health Research Institute, 2009, http://www.ohri.ca/programs/clinicalepidemiology/oxford.htm.
  16. J. P. T. Higgins and S. Green, Cocharne Handbook for Systematic Reviews of Intervention, The Cochrane Library, 2006.
  17. K. Dickersin, “Publication bias: recognizing the problem, understanding its origins and scope, and preventing harm,” in Publication Biasin Meta-Analysis; Prevention, Assessment and Adjustments, H. R. Rothstein, A. J. Sutton, and M. Borenstein, Eds., pp. 11–33, John Wiley & Sons, Chichester, UK, 2005. View at Google Scholar
  18. D. Moher, A. Liberati, J. Tetzlaff et al., “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009. View at Publisher · View at Google Scholar · View at PubMed
  19. G. Nuzzo, F. Giuliante, F. Ardito et al., “Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience,” Surgery, vol. 143, no. 3, pp. 384–393, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. M. D'Angelica, M. F. Brennan, J. G. Fortner, A. M. Cohen, L. H. Blumgart, and Y. Fong, “Ninety-six five-year survivors after liver Resection for metastatic colorectal cancer,” Journal of the American College of Surgeons, vol. 185, no. 6, pp. 554–559, 1997. View at Google Scholar
  21. A. C. Wei, P. D. Greig, D. Grant, B. Taylor, B. Langer, and S. Gallinger, “Survival after hepatic resection for colorectal metastases: a 10-year experience,” Annals of Surgical Oncology, vol. 13, no. 5, pp. 668–676, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. F. Giuliante, F. Ardito, M. Vellone et al., “Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases,” Journal of Surgical Oncology, vol. 100, no. 7, pp. 538–545, 2009. View at Publisher · View at Google Scholar · View at PubMed
  23. Z. Z. R. Hamady, I. C. Cameron, J. Wyatt, R. K. Prasad, G. J. Toogood, and J. P. A. Lodge, “Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule,” European Journal of Surgical Oncology, vol. 32, no. 5, pp. 557–563, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. R. L. Jamison, J. H. Donohue, D. M. Nagorney, C. B. Rosen, W. S. Harmsen, and D. M. Ilstrup, “Hepatic resection for metastatic colorectal cancer results in cure for some patients,” Archives of Surgery, vol. 132, no. 5, pp. 505–511, 1997. View at Google Scholar
  25. M. Minagawa, M. Makuuchi, G. Torzilli et al., “Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results,” Annals of Surgery, vol. 231, no. 4, pp. 487–499, 2000. View at Publisher · View at Google Scholar
  26. J. Scheele, R. Stang, A. Altendorf-Hofmann, and M. Paul, “Resection of colorectal liver metastases,” World Journal of Surgery, vol. 19, no. 1, pp. 59–71, 1995. View at Publisher · View at Google Scholar
  27. Y. Shimizu, K. Yasui, T. Sano et al., “Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate?” Langenbeck's Archives of Surgery, vol. 392, no. 5, pp. 535–538, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. J. S. Tomlinson, W. R. Jarnagin, R. P. DeMatteo et al., “Actual 10-year survival after resection of colorectal liver metastases defines cure,” Journal of Clinical Oncology, vol. 25, no. 29, pp. 4575–4580, 2007. View at Publisher · View at Google Scholar · View at PubMed
  29. H. J. Wanebo, Q. D. Chu, M. P. Vezeridis, and C. Soderberg, “Patient selection for hepatic resection of colorectal metastases,” Archives of Surgery, vol. 131, no. 3, pp. 322–329, 1996. View at Google Scholar
  30. H. F. Hwitzhur, W. Novotony et al., “Bevacizumab plus irinotecan, flourouracil, and leucovorine for metastatic colorectal cancer,” The New England Journal of Medicine, vol. 350, pp. 2335–2342, 2004. View at Google Scholar
  31. A. Martin, “Resection of liver metastases: When is it worthwhile?” World Journal of Surgery, vol. 11, pp. 511–520, 1987. View at Google Scholar
  32. E. K. Abdalla, J. N. Vauthey, L. M. Ellis et al., “Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases,” Annals of Surgery, vol. 239, no. 6, pp. 818–827, 2004. View at Publisher · View at Google Scholar
  33. S. Truant, D. Huglo, M. Hebbar, O. Ernst, M. Steinling, and F. R. Pruvot, “Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D- glucose positron emission tomography of resectable colorectal liver metastases,” British Journal of Surgery, vol. 92, no. 3, pp. 362–369, 2005. View at Publisher · View at Google Scholar · View at PubMed
  34. D. Elias, O. Baton, L. Sideris et al., “Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases,” Journal of Surgical Oncology, vol. 90, no. 1, pp. 36–42, 2005. View at Publisher · View at Google Scholar · View at PubMed
  35. R. Adam, A. Laurent, D. Azoulay et al., “Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors,” Annals of Surgery, vol. 232, no. 6, pp. 777–785, 2000. View at Publisher · View at Google Scholar
  36. M. S. Roh, “Expanding the indications for hepatic resection in patients with colorectal liver metastases,” Annals of Surgical Oncology, vol. 11, no. 3, pp. 238–239, 2004. View at Publisher · View at Google Scholar
  37. S. A. Shah, R. Haddad, W. Al-Sukhni et al., “Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma,” Journal of the American College of Surgeons, vol. 202, no. 3, pp. 468–475, 2006. View at Publisher · View at Google Scholar · View at PubMed
  38. C. Valls, E. Andía, A. Sánchez et al., “Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT,” Radiology, vol. 218, no. 1, pp. 55–60, 2001. View at Google Scholar
  39. C. Valls, E. Lopez, A. Gumà et al., “Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma,” American Journal of Roentgenology, vol. 170, no. 5, pp. 1341–1347, 1998. View at Google Scholar
  40. F. G. Fernandez, J. A. Drebin, D. C. Linehan et al., “Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET),” Annals of Surgery, vol. 240, no. 3, pp. 438–450, 2004. View at Publisher · View at Google Scholar
  41. A. de Gramont, A. Figer, M. Seymour et al., “Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer,” Journal of Clinical Oncology, vol. 18, no. 16, pp. 2938–2947, 2000. View at Google Scholar
  42. L. B. Saltz, J. V. Cox, C. Blanke et al., “Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer,” The New England Journal of Medicine, vol. 343, no. 13, pp. 905–914, 2000. View at Publisher · View at Google Scholar